Sahajanand Medical Technologies Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sahajanand Medical Technologies Limited - overview
Established
1998
Location
Surat, Gujarat, India
Primary Industry
Medical Devices & Equipment
About
Sahajanand Medical Technologies Limited specializes in the development and manufacturing of advanced medical devices for coronary and peripheral interventions, addressing critical health conditions such as coronary artery disease. Founded in 1998 in Surat, India, Sahajanand Medical Technologies Limited focuses on producing innovative medical devices. The company has engaged in 7 deals, with its most recent funding round on January 19, 2023, raising INR 2300. 00 mn in a Growth round led by Morgan Stanley Private Equity Asia and Samara Capital.
The current CEO is Ganesh Sabat, while the founder, Dhirajlal Kotadia, has a background in the medical technology sector, contributing to the company's strategic direction. Sahajanand Medical Technologies specializes in developing and manufacturing advanced medical devices for coronary and peripheral interventions. Their product portfolio includes a variety of coronary stents, such as the Supraflex Cruz and Tetriflex, along with PTCA balloon dilatation catheters like Wilma and Pipit. These products are designed to enhance procedural efficacy in treating coronary artery disease, heart attacks, and congenital heart defects.
The company primarily markets its products to hospitals and healthcare providers across Europe, Asia, and North America, ensuring improved patient outcomes during interventional cardiology procedures. In the fiscal year 2024, Sahajanand Medical Technologies reported a revenue of INR 53,843,750. 90 and an EBITDA of INR 5,215,404. 20.
Revenue is generated through direct sales to healthcare institutions, often involving large orders for their medical devices, reflecting the advanced technology and clinical efficacy of their products. Sahajanand Medical Technologies is focused on launching new products designed for interventional cardiology and expanding its market presence in regions such as Europe and North America by the end of 2024. The recent funding of INR 2300. 00 mn will be allocated to support these product developments and market expansion initiatives.
Additionally, following the acquisition by Kotak Investment Advisors in January 2023, the company aims to leverage new strategic resources to enhance its operational capabilities.
Current Investors
Kotak Alternate Asset Managers, Samara Capital, Morgan Stanley Private Equity Asia
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.smtpl.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Sahajanand Medical Technologies Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Sahajanand Medical Technologies Limited | - | ||||||||
| Secondary Buyout | Completed | Sahajanand Medical Technologies Limited | - | ||||||||
| Growth | Completed | Sahajanand Medical Technologies Limited | - | ||||||||
| Growth | Completed | Sahajanand Medical Technologies Limited | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.